Marcello Casaccia Bertoluci (Marcello C Bertoluci)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Idiopathic Pulmonary Fibrosis

Molecular Docking

Glycemic Control

Epidermal Growth Factor Receptor

Top Venues

Diabetology & metabolic syndrome

Archives of endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Wellington S Silva Júnior, Monica Andrade Lima Gabbay, Rodrigo Nunes Lamounier, Luis Eduardo P Calliari, Marcello Casaccia Bertoluci
The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice. Diabetology & metabolic syndrome 14 (1) (2022)
Wellington S Silva Júnior, Monica Andrade Lima Gabbay, Rodrigo Nunes Lamounier, Luis Eduardo P Calliari, Marcello Casaccia Bertoluci
The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice. Diabetology & metabolic syndrome 14 (1) (2022)
Marcus Vinicius Bolivar Malachias, Magnus Olof Wijkman, Marcello Casaccia Bertoluci
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes. Diabetology & metabolic syndrome 14 (1) (2022)
Lana C Pinto, Marcello Casaccia Bertoluci
Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis. Archives of endocrinology and metabolism 64 (3) (2020)
Marcello Casaccia Bertoluci, João Eduardo Nunes Salles, José Silva-Nunes, Hermelinda Cordeiro Pedrosa, Rodrigo Oliveira Moreira, Rui Manuel Calado da Silva Duarte, Davide Mauricio da Costa Carvalho, Fábio Rogério Trujilho, João Filipe Cancela Dos Santos Raposo, Erika Bezerra Parente, Fernando Valente, Fábio Ferreira de Moura, Alexandre Hohl, Miguel Melo, Francisco Garcia Pestana Araujo, Rosa Maria Monteiro Castro de Araújo Principe, Rosane Kupfer, Adriana Costa E Forti, Cynthia Melissa Valerio, Hélder José Ferreira, João Manuel Sequeira Duarte, José Francisco Kerr Saraiva, Melanie Rodacki, Maria Helane Costa Gurgel Castelo, Mariana Pereira Monteiro, Patrícia Quadros Branco, Pedro Manuel Patricio de Matos, Pedro Carneiro de Melo Pereira de Magalhães, Roberto Tadeu Barcellos Betti, Rosângela Roginski Réa, Thaisa Dourado Guedes Trujilho, Lana Catani Ferreira Pinto, Cristiane Bauermann Leitão
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus. Diabetology & metabolic syndrome 12 (2020)